Trial NCT04703426

View at ClinicalTrials.gov 
Org. Study IDs: 20-370

Last trial update was posted on 2023-05-22

MeSH Interventions

Pembrolizumab Sargramostim

MeSH Conditions

Melanoma

Other Conditions

Metastatic Melanoma Stage III Melanoma Stage IV Melanoma Unresectable Melanoma

Stopping Reasons

Study terminated by sponsor

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID